Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Endocrinology > Male Reproductive Endocrinology > Flashcards

Male Reproductive Endocrinology Flashcards

1
Q

Androgen Regulation

A
  • negative feedback may occur by androgens directly or after conversion to estrogen
  • testosterone (from Leydig cells) primarily involved in negative feedback on LH and GnRH, whereas inhibin (from Sertoli cells) suppresses FSH secretion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Tests of testicular function

A
  • testicular size (lower limit = 4 cm x 2.5 cm)
  • LH, FSH, total, bioavailable, and/or free testosterone

• human chorionic gonadotropin (hCG) stimulation test
■ assesses ability of Leydig cell to respond to gonadotropin

• semen analysis
■ semen volume, sperm concentration, morphology, and motility are the most commonly used parameters

• testicular biopsy
■ indicated with normal FSH and azoospermia/oligospermia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Hypothalamo-pituitary-gonadal axis

A

E45

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Hypogonadism and infertility definition

A

• deficiency in gametogenesis or testosterone production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Hypogonadism and infertility etiology

A
  • causes include primary (testicular failure), secondary (hypot alamic-pituitary failure), and idiopathic
  • primary hypogonadism is more common than secondary
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Diagnosis of Testosterone Deficiency Syndrome aka adult onset primary hypogonadism

A
  • requires clinical manifestations of testosterone deficiency (see sidebar) AND documented testosterone levels below local lab ranges
  • rule out secondary causes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Two distinct features of primary hypogonadism

A
  • The decrease in sperm count is affected to a greater extent than the decrease in serum testosterone level
  • Likely to be associated with gynecomastia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Hypergonadotropic hypogonadism (primary) hypogonadism definition

A

Primary testicular failure
Inc LH and FSH, Inc FSH:LH ratio
Dec testosterone and sperm count

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Two features of secondary hypogonadism

A
  • Associated with an equivalent decrease in sperm count and serum testosterone
  • Less likely to be associated with gynecomastia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Hypergonadotropic hypogonadism (primary) hypogonadism etiology

A 
Congenital 
Chromosomal defects (Klinefelter’s, Noonan) 
Cryptorchidism 
Dsorders of sexual development (DSD) 
Bilateral anorchia (vanishing testicle syndrome) 
Myotonic dystrophy 
Mutation of FSH or LH receptor gene 
Disorders of androgen synthesis

Germ cell defects
Sertoli cell only syndrome
Leydig cell aplasia/failure

Infection/Inflammation
Orchitis – TB, lymphoma, mumps, leprosy
Genital tract infection

Physical factors
Trauma, heat, irradiation, testicular torsion, varicocele

Drugs
Marijuana, alcohol, chemotherapy, ketoconazole, glucocorticoid, spironolactone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Hypergonadotropic hypogonadism (primary) hypogonadism diagnosis

A

Tes icular size and consistency (soft/firm)

Sperm count

LH, FSH, total, and/or bioavailable testosterone

hCG stimulation (mainly used in pediatrics)

Karyotype

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Hypogonadotropic hypogonadism (secondary) hypogonadism definition

A

Hypothalamic-pituitary axis failure

dec LH + FSH (LH sometimes inappropriately normal) dec testosterone and sperm count

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Hypogonadotropic hypogonadism (secondary) hypogonadism etiology

A

Congenital
Kallman’s syndrome
Prader-Willi syndome
Abnormal subunit of LH or FSH

Infection
Tuberculosis, meningitis

Endocrine 
Adrenal androgen excess 
Cushing’s syndrome 
Hypo or hyperthyroidism 
Hypothalamic-pituitary disease (tumour, hyperprolactinemia hypopituitarism)

Drugs
Alcohol, marijuana, spironolactone, ketoconazole, GnRH agonists, androgen/estrogen/progestin use, chronic narcotic use

Chronic illness
Cirrhosis, chronic renal failure, AIDS
Sarcoidosis, Langerhan’s cell histiocytosis hemochromatosis

Critical illness
Surgery, MI, head trauma

Obesity

Idiopathic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Hypogonadotropic hypogonadism (secondary) hypogonadism diagnosis

A

Testicular sze and consistency (soft/firm)

Sperm count

LH, FSH total, and/or bioavailable testosterone

Prolactin levels

MRI of hypothalamic-pituitary region

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Hypogonadism and infertility treatment

A

• goal: testosterone replacement (improve libido, muscle mass strength, body hair growth, bone mass)
■ IM injection, transdermal testosterone patch/gel, oral
■ side effects: acne, fluid retention, erythrocytosis, sleep apnea, benign prostatic hypertrophy, uncertain effects on cardiac events/mortality in older men
■ contraindicated if history of metastatic prostate cancer, breast cancer, severe LUTS associated with BPH, uncontrolled or poorly controlled CHF PSA>4, hematocrit >50%
■ testosterone therapy only to treat symptoms of hypogonadism, often results in decreased spermatogenesis by further suppression of hypothalamic-pituitary-gonad axis

• goal: fertility
■ Treat underlying cause
■ GnRH agonist if hypothalamic dysfunction with intact pituitary, administered SC in pulsatile fashion using an external pump
■ hCG ± recombinant follicular stimulating hormone (rFSH) in cases of either hypothalamic or pituitary lesions
■ Dopamine agonist (eg. bromocriptine, cabergoline) if prolactinoma
■ testicular sperm extraction (TESE) or microscopic sperm extraction (MICROTESE) – only if testicular tissues are not functioning

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Other causes of male infertility

A
  • hereditary disorders: Kartagener syndrome (primary ciliary dyskinesia), cystic fibrosis
  • anatomy: hypospadias, retrograde ejaculation
  • obstruction: vasal occlusion, vasal aplasia, vasectomy, seminal vesicle disease
  • sexual dysfunction: erectile dysfunction, premature ejaculation, infrequent coitus
  • surgery: TURP, radical prostatectomy, orchiectomy
17
Q

Defects in androgen action etiology

A
  • complete androgen insensitivity (CAIS)
  • partial androgen insensitivity (PAIS)
  • 5-α-reductase deficiency
  • mixed gonadal dysgenesis
  • defects in testosterone synthesis
  • infertile male syndrome
  • undervirilized fertile male syndrome
18
Q

Defects in androgen action clinical features

A

depends on age of onset

19
Q

Effects of testosterone deficiency throughout development

A

First Trimester in utero - Incomplete virilization of external genitalia (ambiguous genitalia) Incomplete development of Wolffian ducts to form male internal genitalia (male pseudohermaphrodism)

Third Trimester in utero - Micropenis, Cryptorchidism (failure of normal testicular descent)

Prepuberty - Incomplete pubertal maturation (high pitch voice, sparse pubic + axillary hair, absence of facial hair) Eunuchoidal body habitus (greater growth of extremity long bones relative to axial bones) Poor muscle development, reduced peak bone mass

Postpuberty - Decrease in energy, mood, and libido Fine wrinkles in corners of mouth and eyes Decrease in pubic/axillary hair, hematocrit, muscle mass, strength, and BMD

20
Q

Defects in androgen action treatment

A

appropriate gender assignment in the newborn

  • hormone replacement or supplementation
  • psychological support
  • gonadectomy for cryptorchidism (due to increased risk for testicular cancer)
  • reduction mammoplasty for gynecomastia
21
Q

Infertility definition

A

Infertility: failure of a couple to conceive after 12 mo of regular intercourse without use of contraception in women <35 yr of age; after 6 mo of regular intercourse without use of contraception in women ≥35 yr

22
Q

Infertility history and P/E

A

History • Partner status re: infertility • Length of time for attempt to conceive • Prior successes with other partners • Ejaculation problems • Frequency of interco rse • Prev Surg, Med Hx, STI Hx • Hx orchitis? Cryptorchidism? • Hx toxic exposure? • Medications • Alcohol and illicit drug use • Heat exposure: bath, sauna, whirlpool • Smoking

P/E • General (height, weight, gynecomastia, masculine) • Testicular size and consistency • Varicocele? • Pituitary disease? • Thyroid disease?

23
Q

Infertility investigations

A

Should be considered for couples unable to conceive after 12 mo of unprotected and frequent intercourse. Consider earlier evaluation if suggestive medical Hx and physical, and in women ≥35 yr of age

• Semen analysis x 2 (sperm count, morphology, motility) • Scrotal/testicular U/S (look for varicocele) • Blood work: LH, FSH, testosterone, prolactin, thyroid function tests, DNA fragmentation of sperm, karyotype, Y chromosome deletion • Test female partner

24
Q

Infertility treatment

A
  • No specific therapy for majority of cases
  • Treat specific causes
  • Consider: intrauterine insemination, IVF, therapeutic donor insemination, testicular aspiration of sperm, adoption
25
Q

Gynecomastia definition

A
  • true gynecomastia refers to benign proliferation of the glandular component of the male breast, resulting in the formation of a concentric, rubbery, firm mass extending from the nipple(s)
  • pseudogynecomastia or lipomastia refers to enlargement of soft adipose tissue, especially seen in obese individuals
26
Q

Gynecomastia etiology for physiologic and pathologic

A

Physiologic
• puberty
• elderly (involutional)
• neonatal (maternal hormone)

Pathologic
• endocrinopathies: primary or secondary hypogonadism, hyperthyroidism, extreme hyperprolactinemia, adrenal disease
• tumours: pituitary, adrenal, testicular, breast, ectopic production of hCG
• chronic diseases: cirrhosis, renal, malnutrition (with refeeding)
• drugs: estrogens and estrogen agonists, spironolactone, ketoconazole, cimetidine, digoxin, chemotherapy, marijuana, alcohol
• congenital/genetic: Klinefelter’s syndrome, androgen insensitivity other: idiopathic (majority of gynecomastia is classified as idiopathic), familial

DOC TECH 
Drugs 
Other 
Congenital 
Tumour 
Endocrine 
CHronic disease
27
Q

Gynecomastia pathophysiology

A

• hormonal imbalance due to increased estrogen activity (increased production, or increased availability of estrogen precursors for peripheral conversion to estrogen) or decreased androgen activity (decreased androgen production, binding of androgen to sex hormone binding globulin SHBG), or androgen receptor blockage)

28
Q

Gynecomastia history and physical exam

A
  • recent change in breast characteristics
  • trauma to testicles
  • mumps
  • alcohol and/or drug use
  • FHx
  • sexual dysfunction

• signs of feminization
• breast
■ rule out red flags suggesting breast cancer: unilateral, eccentric, hard or fixed mass, skin dimpling or retraction, and nipple discharge or crusting
■ gynecomastia occurs concentrically around nipple, is not fixed to underlying tissue
• genito-urinary exam
• stigmata of liver or thyroid disease

29
Q

Gynecomastia investigations

A
  • laboratory: serum TSH, PRL, LH, FSH, testosterone, estradiol, LFTs creatinine, hCG (if hCG is elevated need to locate the primary tumour)
  • CXR and CT of chest/abdomen/pelvis (to locate neoplasm)
  • testicular U/S to rule out testicular mass
  • MRI of hypothalamic-pituitary region if pituitary adenoma suspected
30
Q

Gynecomastia treatment

A

initial observation for most men with gynecomastia

• medical
■ correct the underlying disorder, discontinue responsible drug
■ androgens for hypogonadism
■ anti-estrogens: tamoxifen has most evidence for benefit
■ aromatase inhibitors: less evidence of benefit as compared to anti-estrogens

• surgical
■ usually required for macromastia, gynecomastia present for >1 yr (fibrosis is unresponsive to medication), or failed medical treatment and for cosmetic purposes

31
Q

Pubertal gynecomastia age, prognosis and approach

A
  • This benign condition peaks between 13-14 years of age and spontaneously regresses in 90% of cases within 2yr
  • Waiting is often the best approach
32
Q

Occurrence of Gynecomastia

A

3 Peaks

Infancy 60-90%

Puberty 4-69%

Ages 50-80 24-65%

Endocrinology (9 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions